EULAV Asset Management’s NEVRO CORP. NVRO Stock Holding History

EULAV Asset Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,100	Closed	-$276K	–	320
2018 Q4	$276K	Sell	7,100 -98,000	-93%	-$4.36M	0.01%	286
2018 Q3	$5.99M	Buy	105,100 +34,000	+48%	+$2.13M	0.26%	119
2018 Q2	$5.68M	Sell	71,100 -18,300	-20%	-$1.52M	0.26%	116
2018 Q1	$7.75M	Sell	89,400 -13,000	-13%	-$1.05M	0.37%	93
2017 Q4	$7.07M	Sell	102,400 -9,000	-8%	-$720K	0.33%	104
2017 Q3	$10.1M	Sell	111,400 -2,000	-2%	-$171K	0.48%	66
2017 Q2	$8.44M	Buy	113,400 +93,000	+456%	+$7.45M	0.41%	78
2017 Q1	$1.91M	Sell	20,400 -4,000	-16%	-$362K	0.1%	212
2016 Q4	$1.77M	Hold	24,400	–	–	0.1%	216
2016 Q3	$2.55M	Buy	+24,400	New	+$2.2M	0.13%	188

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

EULAV Asset Management's NVRO Position: Q1 2019 in Review

EULAV Asset Management sold out of NEVRO CORP. (NVRO) in Q1 2019, closing a stake of 7,100 shares — an estimated $276K sold.

EULAV Asset Management first reported a position in NVRO in Q3 2016 and held it in 10 quarters. The position peaked at $10.1M in Q3 2017. 172 funds tracked by Wall St. Rank hold NVRO as of Q1 2019.

EULAV Asset Management reported no remaining NEVRO CORP. position as of Q1 2019 after selling out during the quarter.
EULAV Asset Management sold 7,100 NEVRO CORP. shares in Q1 2019, an estimated $276K.
EULAV Asset Management first reported a position in NEVRO CORP. in Q3 2016 and held it in 10 quarters.
EULAV Asset Management's NEVRO CORP. position peaked at $10.1M in Q3 2017.
172 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2019.

Based on EULAV Asset Management's 13F filing for Q1 2019, filed 13 May 2019.